Prostate-specific membrane antigen (PSMA) has transformed how doctors diagnose and treat the disease, offering patients ...

PSMA CT-PET scan is a new powerful imaging tool that will allow physicians to locate suspected metastatic prostate cancer at an earlier stage than was previously available.</p> ...

A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who undergo PSMA ...

The scientists note that, generally speaking, CT scans are useful for detecting ailments like bone and joint problems, but it is difficult for radiologists to use them to detect prostate cancers.

Prostate-specific membrane antigen (PSMA) PET/CT scans, approved by the US FDA in 2020, use a radioactive dye to 'light up' areas of PSMA, which is found on the surface of prostate cancer cells.

PSMA PET/CT scans can detect signs of prostate cancer in elderly patients without the need of a biopsy, diagnose advanced disease and assist in determining which therapy will be most promising for ...

Daniel Oguna, a PET CT technologist prepares a patient for a scan procedure at Aga Khan University Hospital, Nairobi. [Photo: Standard] The latest and most advanced scan for evaluation of patients ...

Data analysis included 182 patients who had a median pre-scan PSA level of 2.6 ng/mL Overall, 84% of the patients had positive PSMA-PET/CT results, including 80% (73 of 91) after radical ...

“PSMA PET/CT scan provides promising accuracy in the field of primary nodal staging for [prostate cancer],” according to Dr Stabile’s team.

A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who undergo PSMA ...